The Magnetic Couples Study: protocol for a mixed methods prospective cohort study of HIV-serodifferent heterosexual couples' perspectives and use of pre-exposure prophylaxis (PrEP).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 07 2021
Historique:
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 5 8 2021
Statut: epublish

Résumé

HIV transmission within serodifferent heterosexual couples plays a key role in sustaining the global HIV pandemic. In the USA, transmission within established mixed-status couples accounts for up to half of all new HIV infections among heterosexuals. Oral HIV pre-exposure prophylaxis (PrEP) is a highly effective prevention method, although underutilised among serodifferent couples. Moreover, there is a dearth of research on US HIV-serodifferent couples' perspectives and use of PrEP, alone or in combination with other prevention methods. In this paper, we describe the study protocol for the Magnetic Couples Study, designed to fill critical knowledge gaps regarding HIV-serodifferent heterosexual couples' perspectives, experiences and utilisation of PrEP. The Magnetic Couples Study is a mixed methods prospective cohort study designed to describe temporal patterns and identify determinants at multiple levels (individual, couple, HCF) of PrEP outcomes along the care continuum (PrEP awareness, linkage, uptake, retention and medication adherence) among HIV-serodifferent heterosexual couples residing in New York City. The study will also examine clinical management of PrEP, side effects and changes in sexual-related and substance use-related behaviour. A prospective cohort of 230 mixed-status couples already on oral PrEP was recruited, with quarterly assessments over 18 months; in addition, a cross-sectional sample of 150 mixed-status couples not currently on PrEP was recruited. In-depth semistructured qualitative interviews were conducted with a subsample of 25 couples. Actor-partner interdependence modelling using multilevel analysis will be employed for the analysis of longitudinal dyadic data. Framework analysis will be used to analyse qualitative data. A parallel convergent design will be used for mixed methods integration. The study was approved by the University of Rochester Institutional Review Board (RSRB00052766). Study findings will be disseminated to community members and providers and to researchers and policy makers.

Identifiants

pubmed: 34210734
pii: bmjopen-2021-048993
doi: 10.1136/bmjopen-2021-048993
pmc: PMC8252879
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e048993

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH107371
Pays : United States
Organisme : NIMH NIH HHS
ID : R56 MH103047
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: PLA has received personal fees and grant funding paid to his institution from Gilead Sciences.

Références

BMC Public Health. 2012 Feb 20;12:136
pubmed: 22348625
Drug Alcohol Depend. 2008 Sep 1;97(1-2):44-53
pubmed: 18495380
PLoS Med. 2013;10(9):e1001511
pubmed: 24058300
AIDS Care. 2011 Sep;23(9):1102-10
pubmed: 21476149
J Multidiscip Healthc. 2016 May 04;9:211-7
pubmed: 27217764
AIDS Care. 2017 Jul;29(7):866-869
pubmed: 28147704
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):323-330
pubmed: 32539288
Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56
pubmed: 24279835
PLoS One. 2015 Apr 21;10(4):e0125299
pubmed: 25898138
Cochrane Database Syst Rev. 2002;(1):CD003255
pubmed: 11869658
Lancet. 2008 Jun 28;371(9631):2183-91
pubmed: 18586173
AIDS Behav. 2014 Aug;18(8):1541-7
pubmed: 24213215
AIDS Behav. 2010 Feb;14(1):92-102
pubmed: 19308717
AIDS Patient Care STDS. 2014 Sep;28(9):462-74
pubmed: 25045996
BMC Public Health. 2015 Mar 13;15:241
pubmed: 25885027
Expert Rev Pharmacoecon Outcomes Res. 2016 Aug;16(4):489-99
pubmed: 26488070
AIDS. 2014 Jun 19;28(10):1521-9
pubmed: 24804859
Am J Public Health. 2016 Jan;106(1):e1-e23
pubmed: 26562123
J Interpers Violence. 2017 Dec;32(24):3709-3734
pubmed: 26319710
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038282
AIDS Care. 2018 Oct;30(10):1306-1310
pubmed: 29845871
Int J STD AIDS. 2019 Feb;30(2):147-153
pubmed: 30301426
Am J Public Health. 2009 Jun;99(6):1072-8
pubmed: 19372509
Biometrics. 2001 Mar;57(1):96-102
pubmed: 11252624
AIDS Behav. 2011 Jan;15(1):9-15
pubmed: 20490909
Struct Equ Modeling. 2017;24(1):129-147
pubmed: 31337946
PLoS Med. 2011 Nov;8(11):e1001123
pubmed: 22110407
Multivariate Behav Res. 2001 Apr 1;36(2):155-83
pubmed: 26822107
South Med J. 2013 Oct;106(10):558-64
pubmed: 24096949
J Womens Health (Larchmt). 2004 Dec;13(10):1137-47
pubmed: 15650347
Epidemiol Infect. 2016 Jan;144(1):90-6
pubmed: 25916602
AIDS Behav. 2020 Dec;24(12):3562-3573
pubmed: 32488554
Glob Public Health. 2013;8(2):209-20
pubmed: 23043414
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
PLoS One. 2013;8(2):e55747
pubmed: 23418455
Curr HIV/AIDS Rep. 2014 Dec;11(4):434-46
pubmed: 25145645
Sex Health. 2016 May 26;:
pubmed: 27224942
Sex Transm Dis. 2013 Oct;40(10):784-91
pubmed: 24275728
Health Psychol. 2015 Nov;34(11):1116-22
pubmed: 26010719
AIDS Patient Care STDS. 2013 Apr;27(4):242-7
pubmed: 23565927
Int J STD AIDS. 2009 Oct;20(10):679-82
pubmed: 19815911
J Racial Ethn Health Disparities. 2021 Jun;8(3):763-772
pubmed: 32808192
J Adolesc Health. 2013 Aug;53(2):222-7
pubmed: 23628136
BMC Med Res Methodol. 2003 Oct 31;3:24
pubmed: 14594457
Arch Intern Med. 2010 Sep 27;170(17):1594-601
pubmed: 20625011
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
AIDS Care. 2018 Jan;30(1):121-129
pubmed: 29067843
J Infect Dis. 2012 Feb 1;205(3):358-65
pubmed: 22241800
Health Educ Behav. 2017 Apr;44(2):236-244
pubmed: 28330388
J Assoc Nurses AIDS Care. 2019 May-Jun;30(3):279-291
pubmed: 30672780
Psychol Women Q. 2017 Mar;41(1):89-99
pubmed: 28490832
Lancet. 2013 Oct 5;382(9899):1195-203
pubmed: 23206835
AIDS Res Ther. 2019 Nov 9;16(1):32
pubmed: 31706357
AIDS Behav. 2014 Feb;18(2):195-216
pubmed: 23897125
AIDS Care. 2019 Aug;31(8):932-941
pubmed: 31056924

Auteurs

James M McMahon (JM)

School of Nursing, University of Rochester Medical Center, Rochester, New York, USA james_mcmahon@urmc.rochester.edu.

Janie Simmons (J)

School of Global Public Health, New York University, New York, New York, USA.

Jessica E Haberer (JE)

Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Sharon Mannheimer (S)

Department of Medicine, New York City Health + Hospitals Harlem, New York, New York, USA.
Department of Medicine, Columbia University Medical Center, New York, New York, USA.

Natalie M Leblanc (NM)

School of Nursing, University of Rochester Medical Center, Rochester, New York, USA.

Leilani Torres (L)

School of Nursing, University of Rochester Medical Center, Rochester, New York, USA.

Robert Quiles (R)

School of Nursing, University of Rochester Medical Center, Rochester, New York, USA.

Guillermo Aedo (G)

School of Global Public Health, New York University, New York, New York, USA.

Anabel Javier (A)

School of Global Public Health, New York University, New York, New York, USA.

Amy Braksmajer (A)

Department of Sociology, State University of New York at Geneseo, Geneseo, New York, USA.

Graham Harriman (G)

HIV Health and Human Services Planning Council, New York City Department of Health and Mental Hygiene, Queens, New York, USA.

Nicole Trabold (N)

College of Health Science and Technology, Rochester Institute of Technology, Rochester, New York, USA.

Enrique R Pouget (ER)

Department of Health and Nutrition Sciences, Brooklyn College, The City University of New York, Brooklyn, New York, USA.

Ann Kurth (A)

School of Nursing, Yale University, Orange, Connecticut, USA.

Martez D R Smith (MDR)

School of Nursing, University of Rochester Medical Center, Rochester, New York, USA.

Judith Brasch (J)

School of Nursing, University of Rochester Medical Center, Rochester, New York, USA.

Eric J Podsiadly (EJ)

School of Nursing, University of Rochester Medical Center, Rochester, New York, USA.

Peter L Anderson (PL)

School of Pharmacy and Pharmaceutical Sciences, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH